| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |


From the Departments of Pediatrics and Experimental
Medicine,*
McGill University, Montreal, Quebec, Canada; the
Cancer Genetics Laboratory,
Department of
Biochemistry, University of Otago, Dunedin, New Zealand; and the
GSF-National Research Center for Environmental
Health,
Institute of Mammalian Genetics,
Neuherberg, Germany
PAX2 is a transcription factor belonging to the evolutionarily conserved paired box family and is required during development of the central nervous system and genitourinary axis. Mutations in the PAX2 gene cause a rare autosomal dominant renal-coloboma syndrome, characterized by optic nerve colobomas and renal hypoplasia. Recent analysis of a spontaneous PAX2 mutant mouse model (1Neu) revealed that the major cause of renal hypoplasia is reduced branching of the ureteric bud (UB) and fewer nephrons. We have observed that this abnormality is associated with a striking increase in the number of UB cells undergoing programmed cell death during nephrogenesis. To ascertain whether apoptosis is directly linked to the level of PAX2 expression, we have studied the role of PAX2 in cultured renal cells. We show that mIMCD-3 cells, a murine collecting duct cell line with high endogenous PAX2 expression, undergo apoptosis when transfected with anti-sense PAX2. In contrast, HEK293 cells expressing exogenous PAX2 are protected against apoptotic death induced by caspase-2. PAX2 has no effect on proliferation of embryonic kidney or in cultured kidney cells. Our observations imply a direct role for PAX2 in survival of ureteric bud cells.
This article has been cited by other articles:
![]() |
R. S. Lindoso, K. S. Verdoorn, and M. Einicker-Lamas Renal recovery after injury: the role of Pax-2 Nephrol. Dial. Transplant., June 25, 2009; (2009) gfp307v1. [Full Text] [PDF] |
||||
![]() |
A. H.T. Nguyen, M. Beland, Y. Gaitan, and M. Bouchard Calcineurin A-Binding Protein, a Novel Modulator of the Calcineurin-Nuclear Factor of Activated T-Cell Signaling Pathway, Is Overexpressed in Wilms' Tumors and Promotes Cell Migration Mol. Cancer Res., June 1, 2009; 7(6): 821 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Quinlan, M. Lemire, T. Hudson, H. Qu, A. Benjamin, A. Roy, E. Pascuet, M. Goodyer, C. Raju, Z. Zhang, et al. A Common Variant of the PAX2 Gene Is Associated with Reduced Newborn Kidney Size J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1915 - 1921. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cohen, O. Loutochin, M. Amin, J.-P. Capolicchio, P. Goodyer, and R. Jednak PAX2 is reactivated in urinary tract obstruction and partially protects collecting duct cells from programmed cell death Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1267 - F1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stayner, D. M. Iglesias, P. R. Goodyer, L. Ellis, G. Germino, J. Zhou, and M. R. Eccles Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease Hum. Mol. Genet., December 15, 2006; 15(24): 3520 - 3528. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dziarmaga, P.-A. Hueber, D. Iglesias, N. Hache, A. Jeffs, N. Gendron, A. MacKenzie, M. Eccles, and P. Goodyer Neuronal apoptosis inhibitory protein is expressed in developing kidney and is regulated by PAX2 Am J Physiol Renal Physiol, October 1, 2006; 291(4): F913 - F920. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bariety, C. Mandet, G. S. Hill, and P. Bruneval Parietal Podocytes in Normal Human Glomeruli J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2770 - 2780. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Omori, M. Hida, H. Fujita, H. Takahashi, S. Tanimura, M. Kohno, and M. Awazu Extracellular Signal-Regulated Kinase Inhibition Slows Disease Progression in Mice with Polycystic Kidney Disease J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1604 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dziarmaga, M. Eccles, and P. Goodyer Suppression of Ureteric Bud Apoptosis Rescues Nephron Endowment and Adult Renal Function in Pax2 Mutant Mice J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1568 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Torban, A. Dziarmaga, D. Iglesias, L. L. Chu, T. Vassilieva, M. Little, M. Eccles, M. Discenza, J. Pelletier, and P. Goodyer PAX2 Activates WNT4 Expression during Mammalian Kidney Development J. Biol. Chem., May 5, 2006; 281(18): 12705 - 12712. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fonsato, S. Buttiglieri, M. C. Deregibus, V. Puntorieri, B. Bussolati, and G. Camussi Expression of Pax2 in Human Renal Tumor-Derived Endothelial Cells Sustains Apoptosis Resistance and Angiogenesis Am. J. Pathol., February 1, 2006; 168(2): 706 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Relaix, D. Montarras, S. Zaffran, B. Gayraud-Morel, D. Rocancourt, S. Tajbakhsh, A. Mansouri, A. Cumano, and M. Buckingham Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells J. Cell Biol., January 3, 2006; 172(1): 91 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Desmots, H. R. Russell, Y. Lee, K. Boyd, and P. J. McKinnon The Reaper-Binding Protein Scythe Modulates Apoptosis and Proliferation during Mammalian Development Mol. Cell. Biol., December 1, 2005; 25(23): 10329 - 10337. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Zhang, B. Moini, and J. R. Ingelfinger Angiotensin II Increases Pax-2 Expression in Fetal Kidney Cells Via the AT2 Receptor J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1452 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Woolf, K. L. Price, P. J. Scambler, and P. J.D. Winyard Evolving Concepts in Human Renal Dysplasia J. Am. Soc. Nephrol., April 1, 2004; 15(4): 998 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Buttiglieri, M. C. Deregibus, S. Bravo, P. Cassoni, R. Chiarle, B. Bussolati, and G. Camussi Role of Pax2 in Apoptosis Resistance and Proinvasive Phenotype of Kaposi's Sarcoma Cells J. Biol. Chem., February 6, 2004; 279(6): 4136 - 4143. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Clark, A. Dziarmaga, M. Eccles, and P. Goodyer Rescue of Defective Branching Nephrogenesis in Renal-Coloboma Syndrome by the Caspase Inhibitor, Z-VAD-fmk J. Am. Soc. Nephrol., February 1, 2004; 15(2): 299 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dziarmaga, P. Clark, C. Stayner, J. P. Julien, E. Torban, P. Goodyer, and M. Eccles Ureteric Bud Apoptosis and Renal Hypoplasia in Transgenic PAX2-Bax Fetal Mice Mimics the Renal-Coloboma Syndrome J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2767 - 2774. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maeshima, K. Maeshima, Y. Nojima, and I. Kojima Involvement of Pax-2 in the Action of Activin A on Tubular Cell Regeneration J. Am. Soc. Nephrol., December 1, 2002; 13(12): 2850 - 2859. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bouchard, A. Souabni, M. Mandler, A. Neubuser, and M. Busslinger Nephric lineage specification by Pax2 and Pax8 Genes & Dev., November 15, 2002; 16(22): 2958 - 2970. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |